Cost-effectiveness of Remote Ischemic Conditioning as an Adjunct to Primary Percutaneous Coronary Intervention
This trial is active, not recruiting.
|Condition||st-elevation myocardial infarction|
|Treatment||remote ischemic conditioning|
|Sponsor||University of Aarhus|
|Collaborator||Aarhus University Hospital|
|Start date||February 2007|
|End date||January 2012|
|Trial size||333 participants|
|Trial identifier||NCT02431338, 48241|
The aim of this study is to investigate the cost-effectiveness of remote ischemic conditioning as an adjunct to primary percutaneous coronary intervention from the perspective of a Danish healthcare system.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
|Masking||single blind (outcomes assessor)|
Incremental cost-effectiveness ratio (ICER) = [difference in total cardiovascular medical care costs between treatment groups] / [difference in major adverse cardiac and cerebrovascular event (MACCE)-free survival between treatment groups]
time frame: 4-years of follow-up
Male or female participants at least 18 years old.
Inclusion Criteria: (1) age ≥ 18 years, (2) symptom duration of ≤ 12 hours prior to admission, and (3) ST-segment elevation ≥ 0.1 mV in two or more contiguous electrocardiogram (ECG) leads Exclusion Criteria: (1) diagnosis not confirmed during hospital admission, (2) history of previous myocardial infarction, (3) previous CABG, and (4) chest pain > 12 hours prior to admission
|Official title||Cost-effectiveness of Remote Ischemic Conditioning as an Adjunct to Primary Percutaneous Coronary Intervention in Patients With ST-elevation Myocardial Infarction|
|Principal investigator||Astrid D Sloth, MD|
Call for more information